Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  H. Lundbeck    LUN   DK0010287234

H. LUNDBECK (LUN)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo H. Lundbeck
Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases

H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders.

It operates through the following geographical segments: Europe, the Unites States of America, and International Markets.

Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's.

The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

Number of employees : 4 983 persons.
Sales per Businesses
20152016Delta
DKK (in Million)%DKK (in Million)%
Other Pharmaceuticals3,19522.1%2,99419.2% -6.29%
Cipralex/Lexapro2,59117.9%---
Xenazine2,20115.2%1,57110.1% -28.62%
Onfi1,75712.1%2,40915.4% +37.11%
Azilect1,45710.1%---
Sabril985.006.8%1,3428.6% +36.24%
Abilify Maintena669.004.6%1,1147.1% +66.52%
Other635.004.4%668.004.3% +5.2%
Brintellix/Trintellix629.004.3%1,1057.1% +75.68%
Northera475.003.3%1,0877% +128.84%
Lexapro--2,51816.1%-
Rexulti--826.005.3%-
Sales per Regions
20152016Delta
DKK (in Million)%DKK (in Million)%
United States6,35343.9%8,40453.8% +32.28%
Rest of Europe3,86926.7%2,89118.5% -25.28%
International3,82726.5%3,99325.6% +4.34%
Global518.003.6%325.002.1% -37.26%
Denmark27.000.2%21.000.1% -22.22%
Managers
NameAgeSinceTitle
Kåre Schultz562015President & Chief Executive Officer
Lars Søren Rasmussen582013Chairman
Anders Götzsche502007CFO & Executive VP-Information Technology
Lars Bang551988EVP-Supply Operations & Engineering
Anders Gersel Pedersen MD, PhD662000Executive Vice President-Research & Development
Jørn Møller Mayntzhusen, MBA512002Director & Senior Manager-Supply Optimisation
Mona Elisabeth Elster551994Director
Henrik Sindal Jensen, PhD482004Director
Lene Skole-Sørensen582015Deputy Chairman
Jens Jesper Ovesen, MBA602015Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 198,460,589 60,988,671 30.7% 120,000 0.1% 30.7%
Shareholders
NameEquities%
Lundbeck Foundation 137,351,918 69.2%
OppenheimerFunds, Inc. 4,738,551 2.39%
Wellington Management Co. LLP 3,499,253 1.76%
TIAA-CREF Investment Management LLC 1,529,000 0.77%
BlackRock Fund Advisors 1,442,808 0.73%
Oddo BHF Asset Management SAS 1,408,113 0.71%
The Vanguard Group, Inc. 1,348,895 0.68%
Norges Bank Investment Management 1,222,500 0.62%
ATP Fondsmaeglerselskab A/S 1,197,636 0.60%
Nordea Investment Management AB (Denmark) 971,886 0.49%
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
H. LUNDBECK33.59%11 950
JOHNSON & JOHNSON17.45%364 503
ROCHE HOLDING LTD.4.90%221 492
NOVARTIS8.37%220 936
PFIZER3.08%199 378
MERCK AND COMPANY6.39%171 303
SANOFI6.01%119 827
BAYER11.97%107 019
GLAXOSMITHKLINE3.39%103 206
ELI LILLY AND COMPANY15.11%93 410
BRISTOL-MYERS SQUIBB COMPANY-4.77%91 680
ABBOTT LABORATORIES32.36%88 221
ASTRAZENECA16.10%84 581
ALLERGAN PLC19.50%84 293
NOVO NORDISK A/S7.30%84 148
SHIRE-11.26%48 950
TAKEDA PHARMACEUTICAL CO LTD18.82%40 859
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-16.27%32 966
ASTELLAS PHARMA INC-16.36%25 306
CHUGAI PHARMACEUTICAL CO., LTD.40.39%23 709
MYLAN NV2.67%20 994
Connections : H. Lundbeck
Fertin Pharma A/S
Danish Society of Internal Medicine
Lundbeckfond Invest A/S
The British Chambers of Commerce
Fonden Lundbeck International Neuroscience Foundation
Coloplast Ejendomme A/S
Confederation of Danish Industry
Tryg Forsikring A/S
Lfi Equity A/S
Rosborg Møbler A/S
LEGO A/S
Coloplast Corp.
American Chamber of Commerce Executives, Inc.
Lundbeck Cognitive Therapeutics A/S
Coloplast Danmark A/S
Nokia Solutions & Networks Australia Pty Ltd.
European Society for Medical Oncology
American Society of Clinical Oncology
Nokia Siemens Networks US LLC
International Association for the Study of Lung Cancer
Sunrise Communications AG
Lundbeck Pharma A/S
Danish Society of Medical Oncology
Company contact information
9 Ottiliavej
DK 2500 Valby, Copenhagen
Denmark

Phone : +45 36 30 13 11
Fax : +45 36 30 19 40
Internet : http://www.lundbeck.com
Markets and indexes
- NASDAQ OMX nordic Kopenhagen
- Main Market Large
- OMXC 20 /
Stock Exchange Codes
- ISIN Code :  DK0010287234
- Bloomberg Code :  LUN:DC
- Reuters Code :  LUN.CO
- Datastream Code :  DK:LUND
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem